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INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is characterised by repetitive episodes of upper airway occlusion during sleep. OSAS has been shown to be associated with a variable degree of nasal inflammation, uvula mucosal congestion and bronchial hyperresponsiveness (BHR) (1) . In various studies, the presence of neutrophilic inflammation has been detected in lower airways in induced sputum (2, 3) . It has been reported that sleep apnea in patients diagnosed with asthma may trigger asthma episodes and nasal CPAP which is the conventional treatment for OSAS may be safely used in these patients and this treatment may control asthma episodes, especially nocturnal symptoms (4) . Various studies established the presence of BHR in OSAS patients without asthma. However, conflicting results have been obtained on BHR in patients with OSAS according to these studies. In the study of Devouassoux et al, the rate of BHR has been found to be 11% in OSAS patients (2) . Nevertheless, BHR was found at the rate of 22% and 25% in in the studies of Köktürk and Lin respectively and both studies reported no correlation between the severity of BHR and severity of disease (5, 6) .
The aim of this study was to investigate the presence of BHR in patients with OSAS. In addition, in this study, we examined the factors determining severity of BHR in this patients.
MATERIALS and METHODS

Study Design
Fourty seven patients with the complaints of snoring, witnessed apnea and daytime sleepiness who were diagnosed with OSAS based upon polysomnography results. Informed consent was taken from all patients in the beginning of the study and the study was approved by the local ethical committee. Asthma, bronchiectasis, chronic obstructive pulmonary disease, active smokers, severe systemic diseases, allergic rhinitis, pregnancy, were accepted as exclusion criteria. Patients who had been asthma symptoms such as episodic breathlessness, wheezing, cough, chest tightness were not included. Body mass index (BMI) (kg/m 2 ) was calculated by measuring weight and height. Pulmonary function tests (PFT) were performed with flow sensitive spirometer. Histamine bronchial challenge tests were performed. Their sleeping status was inquired with Epworth sleepiness scale (ESS).
Pulmonary Function Tests
PFT were performed with flow sensitive spirometry (Sensor Medics ® , Vmax spectra 22, USA) according to "American Thoracic Society" (ATS) criterias (7). Forced vital capacity % (FVC%), forced expiratory volume in one second % (FEV 1 ), peak expiratory flow % (PEF%) and FEV 1 /FVC ratio were recorded.
Epworth Sleepiness Scale (ESS)
The ESS is simple, eight item self-administered scale wich is widely used in clinical practice to quantify the level of daytime sleepiness in situations of different soporificity. Is has a total score range of 0-24 and scores > 10 are indicative of excessive daytime sleepiness (8) .
Bronchial Provocation Test
Patients were assessed with a histamine inhalation test to determine their level of BHR. Histamine solution (diphosphate salt, Sigma, Diesenhofen, Germany) was prepared in sterile isotonic saline. The histamine bronchial challenge test was performed according to a standardized procedure (9 
Sleep Study
Overnight polysomnography was performed in all patients by a computerized system (Sensormedics, USA) and included the following variables: electrooculogram (two channels), electroencephalogram (four channels), electromyogram of submental muscles (two channels), electromyogram of the anterior tibialis muscle of both legs (two channels), and electrocardiogram and airflow (oro-nasal canules). Chest and abdominal efforts (two channels) were recorded using inductive plethysmography, arterial oxyhemoglobin saturation (SaO 2 : 1 channel) by pulse oximetry with a finger probe. Sleep was scored using the criteria of Rechtschaffen and Kales for epochs of 20 s by a scorer experienced in the use of standard guidelines (10) . Sleep stages were scored using standard criteria. Apnea was defined as cessation of airflow for 10 s. Hypopnea was defined as a 30% reduction of airflow or respiratory movements accompanied by a 3% decrease in SaO 2 and/or followed by an arousal. The AHI was established as the ratio of the number of apnoeas and hypopnoeas per hour of sleep. Subjects with an AHI of < 5 were classified as nonapneic snorers (11) .
Statistical Analysis
Results are expressed as mean ± standard deviation (SD). Significance of difference between groups was assessed by unpaired student's t-test. The relation between presence of BHR and AHI, ESS score and BMI was investigated with "pearson correlation test". In "multiple linear regression"analysis, the relation of PD 20 value with AHI, BMI, age and sex, was investigated in patients with BHR. In additon, in "logistic regression"analysis, the relation of presence of BHR with AHI, BMI, age and sex was investigated in all patients with sleep apnea. The statistical analysis was performed using the SPSS program (SPSS Inc., IL, USA) and pvalues were two tailed analysed. p values of less than 0.05 were considered statistically significant.
RESULTS
The study included 37 male and 10 female patients. The mean age was 48.0 ± 11.1 (minimum: 21-maximum: 76) years, the mean BMI was 30.4 ± 4.4 kg/m 2 , the mean AHI was 38.2 ± 28.5 events per h, the mean ESS scores was 10.1 ± 5.9 ( 
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Tuberk Toraks 2013; 61(3): 221-226 sex (Table 4) . Besides, in logistic regression analysis, the relation between presence of BHR and age, sex, AHI and BMI was analysed in the all of patients with sleep apnea. Statistically significant positive relative was found between presence of BHR and AHI (p= 0.04) and BMI (p= 0.03) but presence of BHR did not show significant association with age, sex ( Table 5) .
DISCUSSION
In the present study, rate of BHR in patients with OSAS was as high as 44%. The presence and severity of BHR were correlated with severity of sleep apnea (AHI), BMI and ESS score according to pearson correlation analyses. In addition, AHI was determining presence and severity of BHR and BMI were determining only presence of BHR in multivariate analysis. As severity of OSAS increased, presence and severity of BHR increased. In additon, this results showed that BMI was also increased presence of BHR in patients with sleep apnea.
In the literature, in a large cohort of OSAS patients, airway hyperresponsiveness to cold air has been reported as 4% (12) . In addition, previous studies on BHR in patients with OSAS have indicated equivocal results. When Lin et al. used maximum metacholin dose at 25 mg, they established 25% BHR in patients with OSAS (5). The other study showed that three patients had BHR on methacholine challenge among sexteen patients with OSAS (13). In the our study, maxium histamin dose was 16 mg and BHR was established at the rate of 44%. In other studies, there was not the relation between severity of OSAS and BHR (4, 5) . However, Livy et al. established that at 2 nd -3 rd month of CPAP treatment in OSAS patients BHR was decreased (5). Devoassoux et al. used 4 mg as maximum metacholin dose and found 11% BHR in patients with OSAS (2). They found BHR as 40% at the first weeek of CPAP treatment and as 33% at fourth week in the patients with OSAS, they explained that BHR increased with CPAP Bronchial hyperresponsiveness in patients with obstructive sleep apnea syndrome
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Tuberk Toraks 2013; 61(3): 221-226 (14) (15) (16) (17) . In patients with OSAS, increases in bronchial inflammation was defined as increase neutrophils, IL-8 counts in induced sputum, and increase NO in exhaled air (4, 5) . The repeated mechanical trauma on the airway vibration and the forceful suction collapse during apneas, likely triggers an inflamatory response locally (18) . Bronchial inflammation is thought to facilitate BHR development (19) .
Although several mechanisms underlying the BHRobesity connection have been proposed, debates still remain. The effect of obesity on BHR have been examined in a lot of studies. It was suggested that subcutaneous abdominal fat was significantly associated with BHR (20) . Litonjua et al. reported that high initial BMI was associated with an increased risk of developing BHR (21) . In the other study was compared BHR between normal and increased weight women and this study suggested overweight or obese women showed a higher prevalence of symptomatic BHR (22) . Obesity is very common in patients with OSAS. The results of sleep apnea and obesity are similar to each other, such as increased cardiovascular disease and increased mortality rates. While obesity is the primary risk factor for the development systemic inflammation and sleep apnea, sleep apnea may increases the inflammatory and metabolic disorders (23, 24) . Obesity as a state of chronic systemic inflammation resulting from interactions between adipocytes and adipose tissue macrophages that are recruited to obese adipose tissue. This inflammation, particularly obesity-related changes in TNF-α, leptin, and adiponectin, may contribute to airway hyperresponsiveness in obesity (25) . In the present study, both severity of sleep apnea and BMI were determining presence of BHR as independent of each other. In this study we showed that the effect of obesity on severity of BHR did not reach statistical significant according to multiple linear regression analysis because our study had a small number of patients. In support of this β value of BMI was higher enough in multivariable linear regression analysis examining the relation between degree of BHR and BMI. Besides, it was showed the correlation between degree of BHR (PD values) and BMI in the simple pearson analyses.
In conclusion, BHR is common in patients with OSAS. Degree of BHR increases depending on severity of sleep apnea and accompanying obesity. In addition, patients with BHR is more obese, their disease is more severe. Presence of BHR in OSAS should be taken into account.
